Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Clinical trial NCT04305769 · RECRUITING

Trial details

NCT number: NCT04305769
Sponsor: University of Virginia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridioides Difficile Infection Clostridium Difficile Infection Clostridium Difficile Diarrhea Clostridia Difficile Colitis

Start date: 2021-06-01
Primary completion: 2026-12-31
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.